EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Performance of Liquid Biopsy‐Based Multi‐Omics Biomarkers for Early Detection of Gynecological Malignancies: A Prospective Study (PERCEIVE‐I)

Zheng Feng, Huijuan Ge, Jingshu Wang, Yanan Wang, Xiaoran Sun, Bo Yang, Siyu Cao, Chenlian Quan, Qinhao Guo, Yusheng Han, Feidie Duan, Fang Liu und 6 weitere

Advanced Science · 2025-05 · 12 (20)

DOI: 10.1002/advs.202401760 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Science, online erschienen am 03.04.2025. Verfasst von Zheng Feng und 17 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gynecologic Oncology, Fudan University Shanghai Cancer Center, Shanghai, 200032, China. Hauptthemen laut MEDLINE: Early Detection of Cancer, Biomarkers, Tumor, Genital Neoplasms, Female. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: General Project of Natural Science Foundation of Shanghai.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Liquid biopsy is a promising approach for early detection of gynecological malignancies. In the PERCEIVE‐I study, gynecological Cancer cases ( n = 249) and age‐matched non‐cancer controls ( n = 249) are randomly divided into training and test sets at a 1:1 ratio. Data derived from multi‐omics assays are obtained including a cell‐free DNA methylation panel targeting ≈490 000 CpG sites, a mutation panel comprising 168 genes, and eight tumor protein markers. The results showed that the methylation model outperformed the protein and mutation models, demonstrating higher sensitivity (77.2%) while maintaining similar specificity. The multi‐omics model combining methylation and protein markers achieved improved sensitivity (81.9%) with a good specificity (96.9%). The sensitivity varied across different stages, ranging from 66.7% to 100%. The model accurately identified the tissue of origin in 72.1% of cases. The superior performance of the methylation model highlights the potential of integrating multi‐omics for non‐invasive early detection of gynecological malignancies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Early Detection of CancerBiomarkers, TumorGenital Neoplasms, FemaleHumansFemaleLiquid BiopsyProspective StudiesDNA MethylationMiddle AgedAdultSensitivity and SpecificityAgedMultiomics

Stichwörter der Autor:innen

cancer detectiongynecological malignancyliquid biopsymethylation

Substanzen

Biomarkers, Tumor

Autor:innen und Institutionen

  • Department of Gynecologic Oncology, Fudan University Shanghai Cancer Center, Shanghai, 200032, China.
  • Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, 200032, China.
  • Department of Pathology, Fudan University Shanghai Cancer Center, Shanghai, 200032, China.
  • Burning Rock Biotech, Guangdong, 510300, China.

ORCID-Profile: Hao Wen

Förderung

  • General Project of Natural Science Foundation of Shanghai

Zitieren

APA

Feng, Z., Ge, H., Wang, J., Wang, Y., Sun, X., Yang, B., Cao, S., Quan, C., Guo, Q., Han, Y., Duan, F., Liu, F., Zhao, J., Wang, G., Zhang, Y., Cai, S., Wu, X., & Wen, H. (2025). Performance of Liquid Biopsy‐Based Multi‐Omics Biomarkers for Early Detection of Gynecological Malignancies: A Prospective Study (PERCEIVE‐I). Advanced Science, 12(20). https://doi.org/10.1002/advs.202401760

Vancouver

Feng Z, Ge H, Wang J, Wang Y, Sun X, Yang B, et al. Performance of Liquid Biopsy‐Based Multi‐Omics Biomarkers for Early Detection of Gynecological Malignancies: A Prospective Study (PERCEIVE‐I). Advanced Science. 2025;12(20). doi:10.1002/advs.202401760

BibTeX
@article{Feng2025,
  author = {Feng, Zheng and Ge, Huijuan and Wang, Jingshu and Wang, Yanan and Sun, Xiaoran and Yang, Bo and Cao, Siyu and Quan, Chenlian and Guo, Qinhao and Han, Yusheng and Duan, Feidie and Liu, Fang and Zhao, Jing and Wang, Guoqiang and Zhang, Yuzi and Cai, Shangli and Wu, Xiaohua and Wen, Hao},
  title = {Performance of Liquid Biopsy‐Based Multi‐Omics Biomarkers for Early Detection of Gynecological Malignancies: A Prospective Study (PERCEIVE‐I)},
  journal = {Advanced Science},
  year = {2025},
  volume = {12},
  number = {20},
  doi = {10.1002/advs.202401760}
}
Kostenlos starten →